171 related articles for article (PubMed ID: 25965779)
1. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids.
Reiter C; Fröhlich T; Zeino M; Marschall M; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Hampel F; Efferth T; Tsogoeva SB
Eur J Med Chem; 2015 Jun; 97():164-72. PubMed ID: 25965779
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
Reiter C; Capcı Karagöz A; Fröhlich T; Klein V; Zeino M; Viertel K; Held J; Mordmüller B; Emirdağ Öztürk S; Anıl H; Efferth T; Tsogoeva SB
Eur J Med Chem; 2014 Mar; 75():403-12. PubMed ID: 24561670
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids.
de Lange C; Coertzen D; Smit FJ; Wentzel JF; Wong HN; Birkholtz LM; Haynes RK; N'Da DD
Bioorg Med Chem Lett; 2018 Oct; 28(19):3161-3163. PubMed ID: 30174153
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new betulinic acid/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities.
Karagöz AÇ; Leidenberger M; Hahn F; Hampel F; Friedrich O; Marschall M; Kappes B; Tsogoeva SB
Bioorg Med Chem; 2019 Jan; 27(1):110-115. PubMed ID: 30503412
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives.
de Lange C; Coertzen D; Smit FJ; Wentzel JF; Wong HN; Birkholtz LM; Haynes RK; N'Da DD
Bioorg Med Chem Lett; 2018 Feb; 28(3):289-292. PubMed ID: 29317166
[TBL] [Abstract][Full Text] [Related]
7. Current scenario of ferrocene-containing hybrids for antimalarial activity.
Xiao J; Sun Z; Kong F; Gao F
Eur J Med Chem; 2020 Jan; 185():111791. PubMed ID: 31669852
[TBL] [Abstract][Full Text] [Related]
8. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.
Reiter C; Fröhlich T; Gruber L; Hutterer C; Marschall M; Voigtländer C; Friedrich O; Kappes B; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2015 Sep; 23(17):5452-8. PubMed ID: 26260339
[TBL] [Abstract][Full Text] [Related]
9. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Nqoro X; Aderibigbe BA
Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
[TBL] [Abstract][Full Text] [Related]
10. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
11. Efficient and stereocontrolled synthesis of 1,2,4-trioxolanes useful for ferrous iron-dependent drug delivery.
Fontaine SD; DiPasquale AG; Renslo AR
Org Lett; 2014 Nov; 16(21):5776-9. PubMed ID: 25331549
[TBL] [Abstract][Full Text] [Related]
12. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
13. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against
Fröhlich T; Reiter C; Ibrahim MM; Beutel J; Hutterer C; Zeitträger I; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Efferth T; Marschall M; Tsogoeva SB
ACS Omega; 2017 Jun; 2(6):2422-2431. PubMed ID: 30023664
[TBL] [Abstract][Full Text] [Related]
15. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
Peter S; Aderibigbe BA
Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents.
Fröhlich T; Reiter C; Saeed MEM; Hutterer C; Hahn F; Leidenberger M; Friedrich O; Kappes B; Marschall M; Efferth T; Tsogoeva SB
ACS Med Chem Lett; 2018 Jun; 9(6):534-539. PubMed ID: 29937978
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin Derivatives and Synthetic Trioxane Trigger Apoptotic Cell Death in Asexual Stages of
Gunjan S; Sharma T; Yadav K; Chauhan BS; Singh SK; Siddiqi MI; Tripathi R
Front Cell Infect Microbiol; 2018; 8():256. PubMed ID: 30094226
[TBL] [Abstract][Full Text] [Related]
18. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
[TBL] [Abstract][Full Text] [Related]
19. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
